Alloy Therapeutics

About:

Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.

Website: https://www.alloytx.com

Twitter/X: alloytx

Top Investors: Alexandria Venture Investments, Bossanova Investimentos, Gaingels, 8VC, Founders Fund

Description:

Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.

Total Funding Amount:

$128M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2017-01-01

Hub Tags:

Emerging Unicorn

Founders:

Errik Anderson

Number of Employees:

11-50

Last Funding Date:

2022-10-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai